UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice.	"UFT	0	3	Chemical"	"murine	60	66	Organism"	"renal cell carcinoma	67	87	Cancer"	"dorsal air sac	108	122	Multi"	"mice	132	136	Organism"	"[{""token"": ""UFT"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Chemical""}, {""token"": ""murine"", ""start_span"": 60, ""end_span"": 66, ""type"": ""Organism""}, {""token"": ""renal cell carcinoma"", ""start_span"": 67, ""end_span"": 87, ""type"": ""Cancer""}, {""token"": ""dorsal air sac"", ""start_span"": 108, ""end_span"": 122, ""type"": ""Multi""}, {""token"": ""mice"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Organism""}]"
Nitric oxide synthase inhibition results in synergistic anti - tumour activity with melphalan and tumour necrosis factor alpha - based isolated limb perfusions.	"Nitric oxide synthase	0	21	Gene_or_gene_product"	"tumour	63	69	Cancer"	"melphalan	84	93	Chemical"	"tumour necrosis factor alpha	98	126	Gene_or_gene_product"	"limb	144	148	Organism_subdivision"	"[{""token"": ""Nitric oxide synthase"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumour"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Cancer""}, {""token"": ""melphalan"", ""start_span"": 84, ""end_span"": 93, ""type"": ""Chemical""}, {""token"": ""tumour necrosis factor alpha"", ""start_span"": 98, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""limb"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Organism_subdivision""}]"
Nitric oxide ( NO) is an important molecule in regulating tumour blood flow and stimulating tumour angiogenesis.	"Nitric oxide	0	12	Chemical"	"NO	15	17	Chemical"	"tumour	58	64	Cancer"	"blood	65	70	Organism_substance"	"tumour	92	98	Cancer"	"[{""token"": ""Nitric oxide"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Chemical""}, {""token"": ""NO"", ""start_span"": 15, ""end_span"": 17, ""type"": ""Chemical""}, {""token"": ""tumour"", ""start_span"": 58, ""end_span"": 64, ""type"": ""Cancer""}, {""token"": ""blood"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Organism_substance""}, {""token"": ""tumour"", ""start_span"": 92, ""end_span"": 98, ""type"": ""Cancer""}]"
Moreover, regional administration of L - NAME, in combination with TNF and melphalan, was studied in an isolated limb perfusion ( ILP) model using BN175 soft - tissue sarcomas.	"L - NAME	37	45	Chemical"	"TNF	67	70	Gene_or_gene_product"	"melphalan	75	84	Chemical"	"limb	113	117	Organism_subdivision"	"BN175 soft - tissue sarcomas	147	175	Cancer"	"[{""token"": ""L - NAME"", ""start_span"": 37, ""end_span"": 45, ""type"": ""Chemical""}, {""token"": ""TNF"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""melphalan"", ""start_span"": 75, ""end_span"": 84, ""type"": ""Chemical""}, {""token"": ""limb"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Organism_subdivision""}, {""token"": ""BN175 soft - tissue sarcomas"", ""start_span"": 147, ""end_span"": 175, ""type"": ""Cancer""}]"
We have, therefore, measured the mRNA level of VEGF - B and VEGF - C together with their receptors by RNase protection assay ( RPA) in 26 normal kidney samples and 45 renal cell cancers.	"VEGF - B	47	55	Gene_or_gene_product"	"VEGF - C	60	68	Gene_or_gene_product"	"RNase	102	107	Gene_or_gene_product"	"normal kidney samples	138	159	Multi"	"renal cell cancers	167	185	Cancer"	"[{""token"": ""VEGF - B"", ""start_span"": 47, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C"", ""start_span"": 60, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""RNase"", ""start_span"": 102, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""normal kidney samples"", ""start_span"": 138, ""end_span"": 159, ""type"": ""Multi""}, {""token"": ""renal cell cancers"", ""start_span"": 167, ""end_span"": 185, ""type"": ""Cancer""}]"
There was also a significant correlation between VEGF - C and both of its receptors flt - 4 ( P = 0. 006) and KDR ( P = 0. 03) but no association between VEGF - B and its receptor flt - 1 ( P = 0. 23).	"VEGF - C	49	57	Gene_or_gene_product"	"flt - 4	84	91	Gene_or_gene_product"	"KDR	110	113	Gene_or_gene_product"	"VEGF - B	154	162	Gene_or_gene_product"	"flt - 1	180	187	Gene_or_gene_product"	"[{""token"": ""VEGF - C"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""flt - 4"", ""start_span"": 84, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - B"", ""start_span"": 154, ""end_span"": 162, ""type"": ""Gene_or_gene_product""}, {""token"": ""flt - 1"", ""start_span"": 180, ""end_span"": 187, ""type"": ""Gene_or_gene_product""}]"
Hepatomas exhibiting this phenotype are dependent on the high expression of type II hexokinase, which supplies such tumors with abundant amounts of glucose 6 - phosphate, a significant carbon and energy source especially under hypoxic conditions.	"Hepatomas	0	9	Cancer"	"type II hexokinase	76	94	Gene_or_gene_product"	"tumors	116	122	Cancer"	"glucose 6 - phosphate	148	169	Chemical"	"carbon	185	191	Chemical"	"[{""token"": ""Hepatomas"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Cancer""}, {""token"": ""type II hexokinase"", ""start_span"": 76, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 116, ""end_span"": 122, ""type"": ""Cancer""}, {""token"": ""glucose 6 - phosphate"", ""start_span"": 148, ""end_span"": 169, ""type"": ""Chemical""}, {""token"": ""carbon"", ""start_span"": 185, ""end_span"": 191, ""type"": ""Chemical""}]"
Here we report that the distal region of the hepatoma type II hexokinase promoter displays consensus motifs for hypoxia - inducible factor ( HIF - 1) that overlap E - box sequences known to be related in other gene promoters to glucose response.	"hepatoma	45	53	Cancer"	"type II hexokinase	54	72	Gene_or_gene_product"	"hypoxia - inducible factor	112	138	Gene_or_gene_product"	"HIF - 1	141	148	Gene_or_gene_product"	"glucose	228	235	Chemical"	"[{""token"": ""hepatoma"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Cancer""}, {""token"": ""type II hexokinase"", ""start_span"": 54, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""hypoxia - inducible factor"", ""start_span"": 112, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1"", ""start_span"": 141, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}, {""token"": ""glucose"", ""start_span"": 228, ""end_span"": 235, ""type"": ""Chemical""}]"
In summary, these novel studies identify and characterize a marked glucose - modulated activation response of the type II hexokinase gene to hypoxic conditions within highly glycolytic hepatoma cells, a property that may help assure that such cells exhibit a growth and survival advantage over their parental cells of origin.	"glucose	67	74	Chemical"	"type II hexokinase	114	132	Gene_or_gene_product"	"hepatoma cells	185	199	Cell"	"cells	243	248	Cell"	"parental cells	300	314	Cell"	"[{""token"": ""glucose"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Chemical""}, {""token"": ""type II hexokinase"", ""start_span"": 114, ""end_span"": 132, ""type"": ""Gene_or_gene_product""}, {""token"": ""hepatoma cells"", ""start_span"": 185, ""end_span"": 199, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 243, ""end_span"": 248, ""type"": ""Cell""}, {""token"": ""parental cells"", ""start_span"": 300, ""end_span"": 314, ""type"": ""Cell""}]"
Multiple stages of malignant transformation of human endothelial cells modelled by co - expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N - ras.	"human	47	52	Organism"	"endothelial cells	53	70	Cell"	"telomerase reverse transcriptase	102	134	Gene_or_gene_product"	"SV40 T antigen	136	150	Gene_or_gene_product"	"N - ras	165	172	Gene_or_gene_product"	"[{""token"": ""human"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Organism""}, {""token"": ""endothelial cells"", ""start_span"": 53, ""end_span"": 70, ""type"": ""Cell""}, {""token"": ""telomerase reverse transcriptase"", ""start_span"": 102, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV40 T antigen"", ""start_span"": 136, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}, {""token"": ""N - ras"", ""start_span"": 165, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}]"
BMECs co - expressing SV40T, hTERT and N - ras exhibited an overtly transformed phenotype; forming very large colonies with an altered morphology and generating rapidly growing tumours in vivo.	"BMECs	0	5	Cell"	"SV40T	22	27	Gene_or_gene_product"	"hTERT	29	34	Gene_or_gene_product"	"N - ras	39	46	Gene_or_gene_product"	"tumours	177	184	Cancer"	"[{""token"": ""BMECs"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Cell""}, {""token"": ""SV40T"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""hTERT"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""N - ras"", ""start_span"": 39, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumours"", ""start_span"": 177, ""end_span"": 184, ""type"": ""Cancer""}]"
METHODS: Forty - one patients ( 41 eyes) with a clinical diagnosis of exudative ARMD with PED underwent simultaneous fluorescein and indocyanine green angiography, also under high ( 10 degrees) magnification.	"patients	21	29	Organism"	"eyes	35	39	Organ"	"PED	90	93	Pathological_formation"	"fluorescein	117	128	Chemical"	"indocyanine green	133	150	Chemical"	"[{""token"": ""patients"", ""start_span"": 21, ""end_span"": 29, ""type"": ""Organism""}, {""token"": ""eyes"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Organ""}, {""token"": ""PED"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Pathological_formation""}, {""token"": ""fluorescein"", ""start_span"": 117, ""end_span"": 128, ""type"": ""Chemical""}, {""token"": ""indocyanine green"", ""start_span"": 133, ""end_span"": 150, ""type"": ""Chemical""}]"
CONCLUSIONS: Retinal vasculopathies may be observed in eyes with PED and are detectable by indocyanine green and fluorescein angiography.	"Retinal	13	20	Multi"	"eyes	55	59	Organ"	"PED	65	68	Pathological_formation"	"indocyanine green	91	108	Chemical"	"fluorescein	113	124	Chemical"	"[{""token"": ""Retinal"", ""start_span"": 13, ""end_span"": 20, ""type"": ""Multi""}, {""token"": ""eyes"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Organ""}, {""token"": ""PED"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Pathological_formation""}, {""token"": ""indocyanine green"", ""start_span"": 91, ""end_span"": 108, ""type"": ""Chemical""}, {""token"": ""fluorescein"", ""start_span"": 113, ""end_span"": 124, ""type"": ""Chemical""}]"
Fas - Fas ligand signaling pathway mediates an interleukin - 12 - induced rejection of a murine prostate tumor system.	"Fas	0	3	Gene_or_gene_product"	"Fas ligand	6	16	Gene_or_gene_product"	"interleukin - 12	47	63	Gene_or_gene_product"	"murine	89	95	Organism"	"prostate tumor	96	110	Cancer"	"[{""token"": ""Fas"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas ligand"", ""start_span"": 6, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""interleukin - 12"", ""start_span"": 47, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""murine"", ""start_span"": 89, ""end_span"": 95, ""type"": ""Organism""}, {""token"": ""prostate tumor"", ""start_span"": 96, ""end_span"": 110, ""type"": ""Cancer""}]"
Fas ( APO - 1 / CD95) is a type I membrane protein that is capable of initiating an apoptosis signaling pathway when bound to its ligand ( FasL).	"Fas	0	3	Gene_or_gene_product"	"APO - 1	6	13	Gene_or_gene_product"	"CD95	16	20	Gene_or_gene_product"	"membrane	34	42	Cellular_component"	"FasL	139	143	Gene_or_gene_product"	"[{""token"": ""Fas"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""APO - 1"", ""start_span"": 6, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD95"", ""start_span"": 16, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""membrane"", ""start_span"": 34, ""end_span"": 42, ""type"": ""Cellular_component""}, {""token"": ""FasL"", ""start_span"": 139, ""end_span"": 143, ""type"": ""Gene_or_gene_product""}]"
METHODS: An mIL - 12 expression vector driven by cytomegalovirus promoter was used to express murine IL - 12 cDNA in the RM - 9 murine prostate carcinoma cell line.	"mIL - 12	12	20	Gene_or_gene_product"	"cytomegalovirus	49	64	Organism"	"murine	94	100	Organism"	"IL - 12	101	108	Gene_or_gene_product"	"RM - 9 murine prostate carcinoma cell line	121	163	Cell"	"[{""token"": ""mIL - 12"", ""start_span"": 12, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytomegalovirus"", ""start_span"": 49, ""end_span"": 64, ""type"": ""Organism""}, {""token"": ""murine"", ""start_span"": 94, ""end_span"": 100, ""type"": ""Organism""}, {""token"": ""IL - 12"", ""start_span"": 101, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""RM - 9 murine prostate carcinoma cell line"", ""start_span"": 121, ""end_span"": 163, ""type"": ""Cell""}]"
RESULTS: IL - 12 - expressing RM - 9 prostate carcinoma cells transplanted into C57BL / J6 mice grew more slowly than control RM - 9 cells and vector control RM - 9 - Luc cells.	"IL - 12	9	16	Gene_or_gene_product"	"RM - 9 prostate carcinoma cells	30	61	Cell"	"C57BL / J6 mice	80	95	Organism"	"RM - 9 cells	126	138	Cell"	"RM - 9 - Luc cells	158	176	Cell"	"[{""token"": ""IL - 12"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""RM - 9 prostate carcinoma cells"", ""start_span"": 30, ""end_span"": 61, ""type"": ""Cell""}, {""token"": ""C57BL / J6 mice"", ""start_span"": 80, ""end_span"": 95, ""type"": ""Organism""}, {""token"": ""RM - 9 cells"", ""start_span"": 126, ""end_span"": 138, ""type"": ""Cell""}, {""token"": ""RM - 9 - Luc cells"", ""start_span"": 158, ""end_span"": 176, ""type"": ""Cell""}]"
Using DsRed - tagged Crk and a fluorescent time - lapse microscope, we showed that Crk was recruited to the nascent focal complex after ephrin - B1 stimulation.	"DsRed	6	11	Chemical"	"Crk	21	24	Gene_or_gene_product"	"Crk	83	86	Gene_or_gene_product"	"nascent focal complex	108	129	Cellular_component"	"ephrin - B1	136	147	Gene_or_gene_product"	"[{""token"": ""DsRed"", ""start_span"": 6, ""end_span"": 11, ""type"": ""Chemical""}, {""token"": ""Crk"", ""start_span"": 21, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""Crk"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""nascent focal complex"", ""start_span"": 108, ""end_span"": 129, ""type"": ""Cellular_component""}, {""token"": ""ephrin - B1"", ""start_span"": 136, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}]"
The necessity of Crk in ephrin - B1 - induced membrane ruffling was shown both by the overexpression of dominant negative Crk mutants and by the depletion of Crk by using RNA interference.	"Crk	17	20	Gene_or_gene_product"	"ephrin - B1	24	35	Gene_or_gene_product"	"membrane	46	54	Cellular_component"	"Crk	122	125	Gene_or_gene_product"	"Crk	158	161	Gene_or_gene_product"	"[{""token"": ""Crk"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""ephrin - B1"", ""start_span"": 24, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""membrane"", ""start_span"": 46, ""end_span"": 54, ""type"": ""Cellular_component""}, {""token"": ""Crk"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""Crk"", ""start_span"": 158, ""end_span"": 161, ""type"": ""Gene_or_gene_product""}]"
FVIIa markedly decreased the number of cells with apoptotic morphology and prevented the DNA degradation as measured by means of TdT - mediated dUTP nick end labeling ( TUNEL).	"FVIIa	0	5	Gene_or_gene_product"	"cells	39	44	Cell"	"DNA	89	92	Cellular_component"	"TdT	129	132	Gene_or_gene_product"	"dUTP	144	148	Chemical"	"[{""token"": ""FVIIa"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Cell""}, {""token"": ""DNA"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Cellular_component""}, {""token"": ""TdT"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Gene_or_gene_product""}, {""token"": ""dUTP"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Chemical""}]"
FVIIa - induced cell survival correlated with the activation of Akt and was inhibited markedly by the specific PI3 - kinase inhibitor, LY294002.	"FVIIa	0	5	Gene_or_gene_product"	"cell	16	20	Cell"	"Akt	64	67	Gene_or_gene_product"	"PI3 - kinase	111	123	Gene_or_gene_product"	"LY294002	135	143	Chemical"	"[{""token"": ""FVIIa"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 16, ""end_span"": 20, ""type"": ""Cell""}, {""token"": ""Akt"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3 - kinase"", ""start_span"": 111, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}, {""token"": ""LY294002"", ""start_span"": 135, ""end_span"": 143, ""type"": ""Chemical""}]"
In conclusion, FVIIa binding to TF provided protection against apoptosis induced by growth factor deprivation, primarily through activation of PI3 - kinase / Akt pathway, and to a lesser extent, p44 / 42 MAPK pathway.	"FVIIa	15	20	Gene_or_gene_product"	"TF	32	34	Gene_or_gene_product"	"PI3 - kinase	143	155	Gene_or_gene_product"	"Akt	158	161	Gene_or_gene_product"	"p44 / 42 MAPK	195	208	Gene_or_gene_product"	"[{""token"": ""FVIIa"", ""start_span"": 15, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""TF"", ""start_span"": 32, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3 - kinase"", ""start_span"": 143, ""end_span"": 155, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 158, ""end_span"": 161, ""type"": ""Gene_or_gene_product""}, {""token"": ""p44 / 42 MAPK"", ""start_span"": 195, ""end_span"": 208, ""type"": ""Gene_or_gene_product""}]"
Balb / c 3T3 cells carrying this NPC - LMP gene showed a transformed cell morphology and were tumorigenic in nude mice.	"Balb / c 3T3 cells	0	18	Cell"	"NPC	33	36	Cancer"	"LMP	39	42	Gene_or_gene_product"	"cell	69	73	Cell"	"nude mice	109	118	Organism"	"[{""token"": ""Balb / c 3T3 cells"", ""start_span"": 0, ""end_span"": 18, ""type"": ""Cell""}, {""token"": ""NPC"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Cancer""}, {""token"": ""LMP"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 69, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""nude mice"", ""start_span"": 109, ""end_span"": 118, ""type"": ""Organism""}]"
Angiogenic factors, in particular vascular endothelial growth factor ( VEGF) and the angiopoietins, Ang - 1 and - 2, have recently generated significant interest, especially in oncology.	"vascular endothelial growth factor	34	68	Gene_or_gene_product"	"VEGF	71	75	Gene_or_gene_product"	"angiopoietins	85	98	Gene_or_gene_product"	"Ang - 1	100	107	Gene_or_gene_product"	"- 2	112	115	Gene_or_gene_product"	"[{""token"": ""vascular endothelial growth factor"", ""start_span"": 34, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""angiopoietins"", ""start_span"": 85, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ang - 1"", ""start_span"": 100, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 2"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}]"
BACKGROUND & # 38; OBJECTIVE: Previous study shows that both vascular endothelial growth - C ( VEGF - C) and tumor - associated macrophages ( TAMs) are related to lymphatic metastasis.	"vascular endothelial growth - C	61	92	Gene_or_gene_product"	"VEGF - C	95	103	Gene_or_gene_product"	"tumor - associated macrophages	109	139	Cell"	"TAMs	142	146	Cell"	"lymphatic	163	172	Organ"	"[{""token"": ""vascular endothelial growth - C"", ""start_span"": 61, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C"", ""start_span"": 95, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor - associated macrophages"", ""start_span"": 109, ""end_span"": 139, ""type"": ""Cell""}, {""token"": ""TAMs"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Cell""}, {""token"": ""lymphatic"", ""start_span"": 163, ""end_span"": 172, ""type"": ""Organ""}]"
In brain, receptors for VEGF have been localized to vascular endothelium, neurons, and glia.	"brain	3	8	Organ"	"VEGF	24	28	Gene_or_gene_product"	"vascular endothelium	52	72	Tissue"	"neurons	74	81	Cell"	"glia	87	91	Cell"	"[{""token"": ""brain"", ""start_span"": 3, ""end_span"": 8, ""type"": ""Organ""}, {""token"": ""VEGF"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelium"", ""start_span"": 52, ""end_span"": 72, ""type"": ""Tissue""}, {""token"": ""neurons"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Cell""}, {""token"": ""glia"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Cell""}]"
VEGF is upregulated after hypoxic injury to the brain, which can occur during cerebral ischemia or high - altitude edema, and has been implicated in the blood - brain barrier breakdown associated with these conditions.	"VEGF	0	4	Gene_or_gene_product"	"brain	48	53	Organ"	"cerebral	78	86	Organ"	"edema	115	120	Pathological_formation"	"blood - brain barrier	153	174	Multi"	"[{""token"": ""VEGF"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""brain"", ""start_span"": 48, ""end_span"": 53, ""type"": ""Organ""}, {""token"": ""cerebral"", ""start_span"": 78, ""end_span"": 86, ""type"": ""Organ""}, {""token"": ""edema"", ""start_span"": 115, ""end_span"": 120, ""type"": ""Pathological_formation""}, {""token"": ""blood - brain barrier"", ""start_span"": 153, ""end_span"": 174, ""type"": ""Multi""}]"
We have described striking increases in VEGF protein in both neurons and glia after pilocarpine - induced status epilepticus in the brain.	"VEGF	40	44	Gene_or_gene_product"	"neurons	61	68	Cell"	"glia	73	77	Cell"	"pilocarpine	84	95	Chemical"	"brain	132	137	Organ"	"[{""token"": ""VEGF"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""neurons"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Cell""}, {""token"": ""glia"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Cell""}, {""token"": ""pilocarpine"", ""start_span"": 84, ""end_span"": 95, ""type"": ""Chemical""}, {""token"": ""brain"", ""start_span"": 132, ""end_span"": 137, ""type"": ""Organ""}]"
Verteporfin has a high affinity for choroidal neovascular membranes, typically found with exudative AMD, and upon photoactivation results in targeted microvascular damage and thrombus formation with resultant vessel occlusion.	"Verteporfin	0	11	Chemical"	"choroidal neovascular membranes	36	67	Multi"	"microvascular	150	163	Tissue"	"thrombus	175	183	Pathological_formation"	"vessel	209	215	Multi"	"[{""token"": ""Verteporfin"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Chemical""}, {""token"": ""choroidal neovascular membranes"", ""start_span"": 36, ""end_span"": 67, ""type"": ""Multi""}, {""token"": ""microvascular"", ""start_span"": 150, ""end_span"": 163, ""type"": ""Tissue""}, {""token"": ""thrombus"", ""start_span"": 175, ""end_span"": 183, ""type"": ""Pathological_formation""}, {""token"": ""vessel"", ""start_span"": 209, ""end_span"": 215, ""type"": ""Multi""}]"
Expression of DCC and netrin - 1 in normal human endometrium and its implication in endometrial carcinogenesis.	"DCC	14	17	Gene_or_gene_product"	"netrin - 1	22	32	Gene_or_gene_product"	"human	43	48	Organism"	"endometrium	49	60	Multi"	"endometrial	84	95	Multi"	"[{""token"": ""DCC"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""netrin - 1"", ""start_span"": 22, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Organism""}, {""token"": ""endometrium"", ""start_span"": 49, ""end_span"": 60, ""type"": ""Multi""}, {""token"": ""endometrial"", ""start_span"": 84, ""end_span"": 95, ""type"": ""Multi""}]"
RESULTS: Endometrial glands in the proliferative and early secretory phase expressed both DCC and netrin - 1, but glands in the late - secretory phase tended to silence DCC expression.	"Endometrial glands	9	27	Multi"	"DCC	90	93	Gene_or_gene_product"	"netrin - 1	98	108	Gene_or_gene_product"	"glands	114	120	Multi"	"DCC	169	172	Gene_or_gene_product"	"[{""token"": ""Endometrial glands"", ""start_span"": 9, ""end_span"": 27, ""type"": ""Multi""}, {""token"": ""DCC"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""netrin - 1"", ""start_span"": 98, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""glands"", ""start_span"": 114, ""end_span"": 120, ""type"": ""Multi""}, {""token"": ""DCC"", ""start_span"": 169, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}]"
BACKGROUND: The MDM2 oncoprotein promotes p53 degradation via ubiquitin, establishing negative feedback control of p53 and consequently affecting cell cycle arrest and apoptosis.	"MDM2	16	20	Gene_or_gene_product"	"p53	42	45	Gene_or_gene_product"	"ubiquitin	62	71	Gene_or_gene_product"	"p53	115	118	Gene_or_gene_product"	"cell	146	150	Cell"	"[{""token"": ""MDM2"", ""start_span"": 16, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""ubiquitin"", ""start_span"": 62, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 146, ""end_span"": 150, ""type"": ""Cell""}]"
METHODS: Of the 456 eligible and analyzable patients ( parent cohort), adequate archival diagnostic tissue specimens from 108 patients were available for MDM2 analysis ( MDM2 cohort).	"patients	44	52	Organism"	"tissue specimens	100	116	Tissue"	"patients	126	134	Organism"	"MDM2	154	158	Gene_or_gene_product"	"MDM2	170	174	Gene_or_gene_product"	"[{""token"": ""patients"", ""start_span"": 44, ""end_span"": 52, ""type"": ""Organism""}, {""token"": ""tissue specimens"", ""start_span"": 100, ""end_span"": 116, ""type"": ""Tissue""}, {""token"": ""patients"", ""start_span"": 126, ""end_span"": 134, ""type"": ""Organism""}, {""token"": ""MDM2"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}, {""token"": ""MDM2"", ""start_span"": 170, ""end_span"": 174, ""type"": ""Gene_or_gene_product""}]"
Thrombospondins, metallo proteases and thrombospondin receptors messenger RNA and protein expression in different tumour sublines of the Dunning prostate cancer model.	"Thrombospondins	0	15	Gene_or_gene_product"	"metallo proteases	17	34	Gene_or_gene_product"	"thrombospondin receptors	39	63	Gene_or_gene_product"	"tumour sublines	114	129	Cancer"	"Dunning prostate cancer	137	160	Cancer"	"[{""token"": ""Thrombospondins"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""metallo proteases"", ""start_span"": 17, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""thrombospondin receptors"", ""start_span"": 39, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumour sublines"", ""start_span"": 114, ""end_span"": 129, ""type"": ""Cancer""}, {""token"": ""Dunning prostate cancer"", ""start_span"": 137, ""end_span"": 160, ""type"": ""Cancer""}]"
The ability of E7 to complex with p600 correlated with its ability to enhance anchorage independence of BPV - 1 E6 - expressing cells.	"E7	15	17	Gene_or_gene_product"	"p600	34	38	Gene_or_gene_product"	"BPV	104	107	Organism"	"E6	112	114	Gene_or_gene_product"	"cells	128	133	Cell"	"[{""token"": ""E7"", ""start_span"": 15, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""p600"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""BPV"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Organism""}, {""token"": ""E6"", ""start_span"": 112, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 128, ""end_span"": 133, ""type"": ""Cell""}]"
In this report, we demonstrate that murine bone marrow contains endothelial progenitors, which arise from a cell with self - renewing capacity, and can integrate into tumor microvasculature, albeit at a very low frequency.	"murine	36	42	Organism"	"bone marrow	43	54	Multi"	"endothelial progenitors	64	87	Cell"	"cell	108	112	Cell"	"tumor microvasculature	167	189	Tissue"	"[{""token"": ""murine"", ""start_span"": 36, ""end_span"": 42, ""type"": ""Organism""}, {""token"": ""bone marrow"", ""start_span"": 43, ""end_span"": 54, ""type"": ""Multi""}, {""token"": ""endothelial progenitors"", ""start_span"": 64, ""end_span"": 87, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Cell""}, {""token"": ""tumor microvasculature"", ""start_span"": 167, ""end_span"": 189, ""type"": ""Tissue""}]"
Furthermore, we demonstrate that increased vascular endothelial growth factor ( VEGF) - A secretion by tumor cells, as well as activation of VEGF receptor - 2 in bone marrow cells does not alter the mobilization and incorporation of marrow - derived endothelial progenitors into tumor vasculature.	"tumor cells	103	114	Cell"	"VEGF receptor - 2	141	158	Gene_or_gene_product"	"bone marrow cells	162	179	Cell"	"marrow - derived endothelial progenitors	233	273	Cell"	"tumor vasculature	279	296	Tissue"	"[{""token"": ""tumor cells"", ""start_span"": 103, ""end_span"": 114, ""type"": ""Cell""}, {""token"": ""VEGF receptor - 2"", ""start_span"": 141, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}, {""token"": ""bone marrow cells"", ""start_span"": 162, ""end_span"": 179, ""type"": ""Cell""}, {""token"": ""marrow - derived endothelial progenitors"", ""start_span"": 233, ""end_span"": 273, ""type"": ""Cell""}, {""token"": ""tumor vasculature"", ""start_span"": 279, ""end_span"": 296, ""type"": ""Tissue""}]"
Finally, in human umbilical cord blood cells, we show that endothelial precursors make up only approximately 1 in 10 ( 7) mononuclear cells but are highly enriched in the CD133 + cell population.	"human	12	17	Organism"	"umbilical cord blood cells	18	44	Cell"	"endothelial precursors	59	81	Cell"	"mononuclear cells	122	139	Cell"	"CD133	171	176	Gene_or_gene_product"	"[{""token"": ""human"", ""start_span"": 12, ""end_span"": 17, ""type"": ""Organism""}, {""token"": ""umbilical cord blood cells"", ""start_span"": 18, ""end_span"": 44, ""type"": ""Cell""}, {""token"": ""endothelial precursors"", ""start_span"": 59, ""end_span"": 81, ""type"": ""Cell""}, {""token"": ""mononuclear cells"", ""start_span"": 122, ""end_span"": 139, ""type"": ""Cell""}, {""token"": ""CD133"", ""start_span"": 171, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}]"
The development of carcinoma was examined in male Wistar rats ( n = 120) exposed to N - methyl - N ' - nitro - N - nitrosoguanidine ( MNNG) in the drinking water ( 83 micrograms / ml) for 16 weeks.	"carcinoma	19	28	Cancer"	"Wistar rats	50	61	Organism"	"N - methyl - N ' - nitro - N - nitrosoguanidine	84	131	Chemical"	"MNNG	134	138	Chemical"	"water	156	161	Chemical"	"[{""token"": ""carcinoma"", ""start_span"": 19, ""end_span"": 28, ""type"": ""Cancer""}, {""token"": ""Wistar rats"", ""start_span"": 50, ""end_span"": 61, ""type"": ""Organism""}, {""token"": ""N - methyl - N ' - nitro - N - nitrosoguanidine"", ""start_span"": 84, ""end_span"": 131, ""type"": ""Chemical""}, {""token"": ""MNNG"", ""start_span"": 134, ""end_span"": 138, ""type"": ""Chemical""}, {""token"": ""water"", ""start_span"": 156, ""end_span"": 161, ""type"": ""Chemical""}]"
Hox 1. 4 and Hox 1. 3, genes abundantly induced in nontransformed clones after 3 days of RA treatment, are expressed in N - ras - transformed cells only after 10 days of RA treatment.	"clones	66	72	Cell"	"RA	89	91	Chemical"	"N - ras	120	127	Gene_or_gene_product"	"cells	142	147	Cell"	"RA	170	172	Chemical"	"[{""token"": ""clones"", ""start_span"": 66, ""end_span"": 72, ""type"": ""Cell""}, {""token"": ""RA"", ""start_span"": 89, ""end_span"": 91, ""type"": ""Chemical""}, {""token"": ""N - ras"", ""start_span"": 120, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 142, ""end_span"": 147, ""type"": ""Cell""}, {""token"": ""RA"", ""start_span"": 170, ""end_span"": 172, ""type"": ""Chemical""}]"
Three patients developed deep vein thromboses and two heavily pretreated patients developed treatment - related acute myelogenous leukemia or myelodysplasia after 3. 7 and 12 months of therapy.	"patients	6	14	Organism"	"deep vein thromboses	25	45	Pathological_formation"	"patients	73	81	Organism"	"acute myelogenous leukemia	112	138	Cancer"	"myelodysplasia	142	156	Pathological_formation"	"[{""token"": ""patients"", ""start_span"": 6, ""end_span"": 14, ""type"": ""Organism""}, {""token"": ""deep vein thromboses"", ""start_span"": 25, ""end_span"": 45, ""type"": ""Pathological_formation""}, {""token"": ""patients"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Organism""}, {""token"": ""acute myelogenous leukemia"", ""start_span"": 112, ""end_span"": 138, ""type"": ""Cancer""}, {""token"": ""myelodysplasia"", ""start_span"": 142, ""end_span"": 156, ""type"": ""Pathological_formation""}]"
Nrf2 heterodimerizes with small Maf protein to strongly activate transcription through the Maf recognition element ( MARE) and Keap1 is an inhibitory regulator of Nrf2.	"Nrf2	0	4	Gene_or_gene_product"	"Maf	32	35	Gene_or_gene_product"	"Maf	91	94	Gene_or_gene_product"	"Keap1	127	132	Gene_or_gene_product"	"Nrf2	163	167	Gene_or_gene_product"	"[{""token"": ""Nrf2"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""Maf"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""Maf"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""Keap1"", ""start_span"": 127, ""end_span"": 132, ""type"": ""Gene_or_gene_product""}, {""token"": ""Nrf2"", ""start_span"": 163, ""end_span"": 167, ""type"": ""Gene_or_gene_product""}]"
On the contrary, the constitutive activation of Nrf2 due to mutations in the keap1 gene is characteristically observed in lung cancer cells, suggesting that induced expression of Nrf2 target genes favors the prevalence of cancer cells.	"Nrf2	48	52	Gene_or_gene_product"	"keap1	77	82	Gene_or_gene_product"	"lung cancer cells	122	139	Cell"	"Nrf2	179	183	Gene_or_gene_product"	"cancer cells	222	234	Cell"	"[{""token"": ""Nrf2"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""keap1"", ""start_span"": 77, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""lung cancer cells"", ""start_span"": 122, ""end_span"": 139, ""type"": ""Cell""}, {""token"": ""Nrf2"", ""start_span"": 179, ""end_span"": 183, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer cells"", ""start_span"": 222, ""end_span"": 234, ""type"": ""Cell""}]"
Maternal endothelial dysfunction in preeclampsia is associated with increased soluble fms - like tyrosine kinase - 1 ( sFlt - 1), a circulating antagonist of vascular endothelial growth factor and placental growth factor.	"endothelial	9	20	Cell"	"fms - like tyrosine kinase - 1	86	116	Gene_or_gene_product"	"sFlt - 1	119	127	Gene_or_gene_product"	"vascular endothelial growth factor	158	192	Gene_or_gene_product"	"placental growth factor	197	220	Gene_or_gene_product"	"[{""token"": ""endothelial"", ""start_span"": 9, ""end_span"": 20, ""type"": ""Cell""}, {""token"": ""fms - like tyrosine kinase - 1"", ""start_span"": 86, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""sFlt - 1"", ""start_span"": 119, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 158, ""end_span"": 192, ""type"": ""Gene_or_gene_product""}, {""token"": ""placental growth factor"", ""start_span"": 197, ""end_span"": 220, ""type"": ""Gene_or_gene_product""}]"
Here we report that infusion of Ang II significantly increases circulating levels of sFlt - 1 in pregnant mice, thereby demonstrating that Ang II is a regulator of sFlt - 1 secretion in vivo.	"Ang II	32	38	Gene_or_gene_product"	"sFlt - 1	85	93	Gene_or_gene_product"	"mice	106	110	Organism"	"Ang II	139	145	Gene_or_gene_product"	"sFlt - 1	164	172	Gene_or_gene_product"	"[{""token"": ""Ang II"", ""start_span"": 32, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""sFlt - 1"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Organism""}, {""token"": ""Ang II"", ""start_span"": 139, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}, {""token"": ""sFlt - 1"", ""start_span"": 164, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}]"
A p53 mutant, p53R172P, which is deficient for apoptosis but retains a partial cell cycle arrest function, delays tumor onset in mice.	"p53	2	5	Gene_or_gene_product"	"p53R172P	14	22	Gene_or_gene_product"	"cell	79	83	Cell"	"tumor	114	119	Cancer"	"mice	129	133	Organism"	"[{""token"": ""p53"", ""start_span"": 2, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53R172P"", ""start_span"": 14, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Organism""}]"
Loss of p21 completely abolished the cell cycle arrest function of p53R172P and accelerated tumor onset in Trp53 ( 515C / 515C) mice.	"p21	8	11	Gene_or_gene_product"	"cell	37	41	Cell"	"p53R172P	67	75	Gene_or_gene_product"	"tumor	92	97	Cancer"	"Trp53	107	112	Gene_or_gene_product"	"[{""token"": ""p21"", ""start_span"": 8, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Cell""}, {""token"": ""p53R172P"", ""start_span"": 67, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Cancer""}, {""token"": ""Trp53"", ""start_span"": 107, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}]"
Thus, p21 coupled p53 - dependent checkpoint control and preservation of chromosomal stability, and cooperated with apoptosis in suppressing tumor onset in mice.	"p21	6	9	Gene_or_gene_product"	"p53	18	21	Gene_or_gene_product"	"chromosomal	73	84	Cellular_component"	"tumor	141	146	Cancer"	"mice	156	160	Organism"	"[{""token"": ""p21"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""chromosomal"", ""start_span"": 73, ""end_span"": 84, ""type"": ""Cellular_component""}, {""token"": ""tumor"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Organism""}]"
Magnolol, a substance purified from the bark of Magnolia officialis, inhibits cell proliferation and induces apoptosis in a variety of cancer cells.	"Magnolol	0	8	Chemical"	"bark	40	44	Tissue"	"Magnolia officialis	48	67	Organism"	"cell	78	82	Cell"	"cancer cells	135	147	Cell"	"[{""token"": ""Magnolol"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical""}, {""token"": ""bark"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Tissue""}, {""token"": ""Magnolia officialis"", ""start_span"": 48, ""end_span"": 67, ""type"": ""Organism""}, {""token"": ""cell"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Cell""}, {""token"": ""cancer cells"", ""start_span"": 135, ""end_span"": 147, ""type"": ""Cell""}]"
Cytochrome - c staining was diffused in the cytoplasm of the apoptotic cells, but restricted to the mitochondria in control cells.	"Cytochrome - c	0	14	Gene_or_gene_product"	"cytoplasm	44	53	Organism_substance"	"cells	71	76	Cell"	"mitochondria	100	112	Cellular_component"	"cells	124	129	Cell"	"[{""token"": ""Cytochrome - c"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytoplasm"", ""start_span"": 44, ""end_span"": 53, ""type"": ""Organism_substance""}, {""token"": ""cells"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Cell""}, {""token"": ""mitochondria"", ""start_span"": 100, ""end_span"": 112, ""type"": ""Cellular_component""}, {""token"": ""cells"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Cell""}]"
Western blot analyses showed an increase in levels of activated caspases ( caspase - 3 and - 7) and of cleaved poly ( ADP - ribose) polymerase ( PARP) by magnolol.	"caspases	64	72	Gene_or_gene_product"	"caspase - 3	75	86	Gene_or_gene_product"	"- 7	91	94	Gene_or_gene_product"	"PARP	145	149	Gene_or_gene_product"	"magnolol	154	162	Chemical"	"[{""token"": ""caspases"", ""start_span"": 64, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase - 3"", ""start_span"": 75, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 7"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""PARP"", ""start_span"": 145, ""end_span"": 149, ""type"": ""Gene_or_gene_product""}, {""token"": ""magnolol"", ""start_span"": 154, ""end_span"": 162, ""type"": ""Chemical""}]"
Inhibition of either PARP or caspase activity blocked magnolol - induced apoptosis, supporting the involvement of the caspases and PARP.	"PARP	21	25	Gene_or_gene_product"	"caspase	29	36	Gene_or_gene_product"	"magnolol	54	62	Chemical"	"caspases	118	126	Gene_or_gene_product"	"PARP	131	135	Gene_or_gene_product"	"[{""token"": ""PARP"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase"", ""start_span"": 29, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""magnolol"", ""start_span"": 54, ""end_span"": 62, ""type"": ""Chemical""}, {""token"": ""caspases"", ""start_span"": 118, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""PARP"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}]"
METHODS: Grafted animals for corneal survival analysis were assigned to receive either spironolactone suspension ( orally, 100 mg / kg / day, n = 7), phosphate - buffered saline ( PBS, orally, same volume as spironolactone, n = 9) or remained untreated ( n = 16).	"corneal	29	36	Multi"	"spironolactone	87	101	Chemical"	"phosphate - buffered saline	150	177	Chemical"	"PBS	180	183	Chemical"	"spironolactone	208	222	Chemical"	"[{""token"": ""corneal"", ""start_span"": 29, ""end_span"": 36, ""type"": ""Multi""}, {""token"": ""spironolactone"", ""start_span"": 87, ""end_span"": 101, ""type"": ""Chemical""}, {""token"": ""phosphate - buffered saline"", ""start_span"": 150, ""end_span"": 177, ""type"": ""Chemical""}, {""token"": ""PBS"", ""start_span"": 180, ""end_span"": 183, ""type"": ""Chemical""}, {""token"": ""spironolactone"", ""start_span"": 208, ""end_span"": 222, ""type"": ""Chemical""}]"
Spironolactone affected both systemic ( down - regulation of CD25 + cells in spleen) and local immune response ( up - regulation of IL - 10 in cornea).	"Spironolactone	0	14	Chemical"	"CD25	61	65	Gene_or_gene_product"	"spleen	77	83	Organ"	"IL - 10	132	139	Gene_or_gene_product"	"cornea	143	149	Multi"	"[{""token"": ""Spironolactone"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Chemical""}, {""token"": ""CD25"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""spleen"", ""start_span"": 77, ""end_span"": 83, ""type"": ""Organ""}, {""token"": ""IL - 10"", ""start_span"": 132, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""cornea"", ""start_span"": 143, ""end_span"": 149, ""type"": ""Multi""}]"
Detection of lymphovascular invasion in early breast cancer by D2 - 40 ( podoplanin): a clinically useful predictor for axillary lymph node metastases.	"lymphovascular	13	27	Multi"	"breast cancer	46	59	Cancer"	"D2 - 40	63	70	Gene_or_gene_product"	"podoplanin	73	83	Gene_or_gene_product"	"lymph node	129	139	Multi"	"[{""token"": ""lymphovascular"", ""start_span"": 13, ""end_span"": 27, ""type"": ""Multi""}, {""token"": ""breast cancer"", ""start_span"": 46, ""end_span"": 59, ""type"": ""Cancer""}, {""token"": ""D2 - 40"", ""start_span"": 63, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""podoplanin"", ""start_span"": 73, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 129, ""end_span"": 139, ""type"": ""Multi""}]"
To better understand the activity of cediranib against VEGFR - 3 and its associated signaling events compared with its activity against VEGFR - 2, we used the receptor - specific ligands VEGF - E and VEGF - C156S.	"cediranib	37	46	Chemical"	"VEGFR - 3	55	64	Gene_or_gene_product"	"VEGFR - 2	136	145	Gene_or_gene_product"	"VEGF - E	187	195	Gene_or_gene_product"	"VEGF - C156S	200	212	Gene_or_gene_product"	"[{""token"": ""cediranib"", ""start_span"": 37, ""end_span"": 46, ""type"": ""Chemical""}, {""token"": ""VEGFR - 3"", ""start_span"": 55, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 2"", ""start_span"": 136, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - E"", ""start_span"": 187, ""end_span"": 195, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C156S"", ""start_span"": 200, ""end_span"": 212, ""type"": ""Gene_or_gene_product""}]"
Additionally, cediranib blocked VEGF - C156S - induced and VEGF - E - induced proliferation, survival, and migration of lymphatic and blood vascular endothelial cells.	"cediranib	14	23	Chemical"	"VEGF - C156S	32	44	Gene_or_gene_product"	"VEGF - E	59	67	Gene_or_gene_product"	"lymphatic	120	129	Cell"	"blood vascular endothelial cells	134	166	Cell"	"[{""token"": ""cediranib"", ""start_span"": 14, ""end_span"": 23, ""type"": ""Chemical""}, {""token"": ""VEGF - C156S"", ""start_span"": 32, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - E"", ""start_span"": 59, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymphatic"", ""start_span"": 120, ""end_span"": 129, ""type"": ""Cell""}, {""token"": ""blood vascular endothelial cells"", ""start_span"": 134, ""end_span"": 166, ""type"": ""Cell""}]"
In this study, we investigated the effect of artemisinin on tumor growth, lymphangiogenesis, metastasis and survival in mouse Lewis lung carcinoma ( LLC) models.	"artemisinin	45	56	Chemical"	"tumor	60	65	Cancer"	"mouse	120	125	Organism"	"Lewis lung carcinoma	126	146	Cancer"	"LLC	149	152	Cancer"	"[{""token"": ""artemisinin"", ""start_span"": 45, ""end_span"": 56, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 60, ""end_span"": 65, ""type"": ""Cancer""}, {""token"": ""mouse"", ""start_span"": 120, ""end_span"": 125, ""type"": ""Organism""}, {""token"": ""Lewis lung carcinoma"", ""start_span"": 126, ""end_span"": 146, ""type"": ""Cancer""}, {""token"": ""LLC"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Cancer""}]"
We found that orally administered artemisinin inhibited lymph node and lung metastasis and prolonged survival without retarding tumor growth.	"orally	14	20	Organism_subdivision"	"artemisinin	34	45	Chemical"	"lymph node	56	66	Multi"	"lung	71	75	Organ"	"tumor	128	133	Cancer"	"[{""token"": ""orally"", ""start_span"": 14, ""end_span"": 20, ""type"": ""Organism_subdivision""}, {""token"": ""artemisinin"", ""start_span"": 34, ""end_span"": 45, ""type"": ""Chemical""}, {""token"": ""lymph node"", ""start_span"": 56, ""end_span"": 66, ""type"": ""Multi""}, {""token"": ""lung"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Organ""}, {""token"": ""tumor"", ""start_span"": 128, ""end_span"": 133, ""type"": ""Cancer""}]"
Bevacizumab is a humanized immunoglobulin G1 monoclonal antibody to vascular endothelial growth factor that has been shown to have activity in malignant gliomas when combined with irinotecan.	"Bevacizumab	0	11	Chemical"	"immunoglobulin G1	27	44	Gene_or_gene_product"	"monoclonal antibody to vascular endothelial growth factor	45	102	Gene_or_gene_product"	"malignant gliomas	143	160	Cancer"	"irinotecan	180	190	Chemical"	"[{""token"": ""Bevacizumab"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Chemical""}, {""token"": ""immunoglobulin G1"", ""start_span"": 27, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""monoclonal antibody to vascular endothelial growth factor"", ""start_span"": 45, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""malignant gliomas"", ""start_span"": 143, ""end_span"": 160, ""type"": ""Cancer""}, {""token"": ""irinotecan"", ""start_span"": 180, ""end_span"": 190, ""type"": ""Chemical""}]"
Endosialin / TEM 1 is a cell membrane protein that is expressed in blood vessels during embryogenesis and tumorigenesis but not in normal mature vessels.	"Endosialin	0	10	Gene_or_gene_product"	"TEM 1	13	18	Gene_or_gene_product"	"cell membrane	24	37	Cellular_component"	"blood vessels	67	80	Multi"	"mature vessels	138	152	Multi"	"[{""token"": ""Endosialin"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""TEM 1"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell membrane"", ""start_span"": 24, ""end_span"": 37, ""type"": ""Cellular_component""}, {""token"": ""blood vessels"", ""start_span"": 67, ""end_span"": 80, ""type"": ""Multi""}, {""token"": ""mature vessels"", ""start_span"": 138, ""end_span"": 152, ""type"": ""Multi""}]"
Transgenic mice engineered to express human endosialin bred on an immunocompromised background allowed the growth of human tumor xenografts.	"mice	11	15	Organism"	"human	38	43	Organism"	"endosialin	44	54	Gene_or_gene_product"	"human	117	122	Organism"	"tumor xenografts	123	139	Cancer"	"[{""token"": ""mice"", ""start_span"": 11, ""end_span"": 15, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 38, ""end_span"": 43, ""type"": ""Organism""}, {""token"": ""endosialin"", ""start_span"": 44, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 117, ""end_span"": 122, ""type"": ""Organism""}, {""token"": ""tumor xenografts"", ""start_span"": 123, ""end_span"": 139, ""type"": ""Cancer""}]"
Similar methods applied to human ovarian and colon tumors confirmed endosialin expression by pericytes.	"human	27	32	Organism"	"ovarian	33	40	Cancer"	"colon tumors	45	57	Cancer"	"endosialin	68	78	Gene_or_gene_product"	"pericytes	93	102	Cell"	"[{""token"": ""human"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Organism""}, {""token"": ""ovarian"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Cancer""}, {""token"": ""colon tumors"", ""start_span"": 45, ""end_span"": 57, ""type"": ""Cancer""}, {""token"": ""endosialin"", ""start_span"": 68, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""pericytes"", ""start_span"": 93, ""end_span"": 102, ""type"": ""Cell""}]"
In hPNAS - 4 - p - treated tumor cells in vivo, tumor growth significantly decreased, while the survival time of tumor - bearing mice was prolonged compared with control groups ( p < 0. 05).	"hPNAS - 4	3	12	Gene_or_gene_product"	"tumor cells	27	38	Cell"	"tumor	48	53	Cancer"	"tumor	113	118	Cancer"	"mice	129	133	Organism"	"[{""token"": ""hPNAS - 4"", ""start_span"": 3, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cells"", ""start_span"": 27, ""end_span"": 38, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 48, ""end_span"": 53, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Organism""}]"
As a result, GSE could inhibit VEGF - induced endothelial cell proliferation and migration as well as sprout formation from aorta ring.	"GSE	13	16	Organism_substance"	"VEGF	31	35	Gene_or_gene_product"	"endothelial cell	46	62	Cell"	"sprout	102	108	Tissue"	"aorta ring	124	134	Multi"	"[{""token"": ""GSE"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Organism_substance""}, {""token"": ""VEGF"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 46, ""end_span"": 62, ""type"": ""Cell""}, {""token"": ""sprout"", ""start_span"": 102, ""end_span"": 108, ""type"": ""Tissue""}, {""token"": ""aorta ring"", ""start_span"": 124, ""end_span"": 134, ""type"": ""Multi""}]"
In vivo assay further showed that GSE could inhibit tumor growth and tumor angiogenesis of MDA - MB - 231 breast cancer cells in mice.	"GSE	34	37	Organism_substance"	"tumor	52	57	Cancer"	"tumor	69	74	Cancer"	"MDA - MB - 231 breast cancer cells	91	125	Cell"	"mice	129	133	Organism"	"[{""token"": ""GSE"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Organism_substance""}, {""token"": ""tumor"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Cancer""}, {""token"": ""MDA - MB - 231 breast cancer cells"", ""start_span"": 91, ""end_span"": 125, ""type"": ""Cell""}, {""token"": ""mice"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Organism""}]"
Consistent with the in vitro data, GSE treatment of tumor - bearing mice led to concomitant reduction of blood vessel density and phosphorylation of mitogen - activated protein kinase.	"GSE	35	38	Organism_substance"	"tumor	52	57	Cancer"	"mice	68	72	Organism"	"blood vessel	105	117	Multi"	"mitogen - activated protein kinase	149	183	Gene_or_gene_product"	"[{""token"": ""GSE"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Organism_substance""}, {""token"": ""tumor"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Organism""}, {""token"": ""blood vessel"", ""start_span"": 105, ""end_span"": 117, ""type"": ""Multi""}, {""token"": ""mitogen - activated protein kinase"", ""start_span"": 149, ""end_span"": 183, ""type"": ""Gene_or_gene_product""}]"
Depletion of polyphenol with polyvinylpyrrolidone abolished the antiangiogenic activity of GSE, suggesting a water - soluble fraction of polyphenol in GSE is responsible for the antiangiogenic activity.	"polyphenol	13	23	Chemical"	"polyvinylpyrrolidone	29	49	Chemical"	"GSE	91	94	Organism_substance"	"polyphenol	137	147	Chemical"	"GSE	151	154	Organism_substance"	"[{""token"": ""polyphenol"", ""start_span"": 13, ""end_span"": 23, ""type"": ""Chemical""}, {""token"": ""polyvinylpyrrolidone"", ""start_span"": 29, ""end_span"": 49, ""type"": ""Chemical""}, {""token"": ""GSE"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Organism_substance""}, {""token"": ""polyphenol"", ""start_span"": 137, ""end_span"": 147, ""type"": ""Chemical""}, {""token"": ""GSE"", ""start_span"": 151, ""end_span"": 154, ""type"": ""Organism_substance""}]"
Our studies demonstrate that IFI16 mediates ICAM - 1 stimulation by TNF - alpha through the NF - kappaB pathway, thus reinforcing the role of the IFI16 molecule in the inflammation process.	"IFI16	29	34	Gene_or_gene_product"	"ICAM - 1	44	52	Gene_or_gene_product"	"TNF - alpha	68	79	Gene_or_gene_product"	"NF - kappaB	92	103	Gene_or_gene_product"	"IFI16	146	151	Gene_or_gene_product"	"[{""token"": ""IFI16"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""ICAM - 1"", ""start_span"": 44, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""TNF - alpha"", ""start_span"": 68, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 92, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""IFI16"", ""start_span"": 146, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}]"
Impact of tumor cell VEGF expression on the in vivo efficacy of vandetanib ( ZACTIMA; ZD6474).	"tumor cell	10	20	Cell"	"VEGF	21	25	Gene_or_gene_product"	"vandetanib	64	74	Chemical"	"ZACTIMA	77	84	Chemical"	"ZD6474	86	92	Chemical"	"[{""token"": ""tumor cell"", ""start_span"": 10, ""end_span"": 20, ""type"": ""Cell""}, {""token"": ""VEGF"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""vandetanib"", ""start_span"": 64, ""end_span"": 74, ""type"": ""Chemical""}, {""token"": ""ZACTIMA"", ""start_span"": 77, ""end_span"": 84, ""type"": ""Chemical""}, {""token"": ""ZD6474"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Chemical""}]"
An intradermal angiogenesis assay was used to demonstrate that a 4 - day treatment with vandetanib ( 50 mg / kg / day) was able to significantly inhibit blood vessel growth induced by both parental and high VEGF - expressing tumor cell clones.	"intradermal	3	14	Multi"	"vandetanib	88	98	Chemical"	"blood vessel	153	165	Multi"	"VEGF	207	211	Gene_or_gene_product"	"tumor cell clones	225	242	Cell"	"[{""token"": ""intradermal"", ""start_span"": 3, ""end_span"": 14, ""type"": ""Multi""}, {""token"": ""vandetanib"", ""start_span"": 88, ""end_span"": 98, ""type"": ""Chemical""}, {""token"": ""blood vessel"", ""start_span"": 153, ""end_span"": 165, ""type"": ""Multi""}, {""token"": ""VEGF"", ""start_span"": 207, ""end_span"": 211, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cell clones"", ""start_span"": 225, ""end_span"": 242, ""type"": ""Cell""}]"
In the HT29 tumor model, treatment response to vandetanib ( 50 mg / kg / day, Monday - Friday for 2 weeks) was greatest in xenografts derived from the highest VEGF - expressing cell clones.	"HT29 tumor	7	17	Cancer"	"vandetanib	47	57	Chemical"	"xenografts	123	133	Cancer"	"VEGF	159	163	Gene_or_gene_product"	"cell clones	177	188	Cell"	"[{""token"": ""HT29 tumor"", ""start_span"": 7, ""end_span"": 17, ""type"": ""Cancer""}, {""token"": ""vandetanib"", ""start_span"": 47, ""end_span"": 57, ""type"": ""Chemical""}, {""token"": ""xenografts"", ""start_span"": 123, ""end_span"": 133, ""type"": ""Cancer""}, {""token"": ""VEGF"", ""start_span"": 159, ""end_span"": 163, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell clones"", ""start_span"": 177, ""end_span"": 188, ""type"": ""Cell""}]"
We previously showed that disruption of TGF - beta signaling by dominant - negative TGF - beta type II receptor in a diffuse - type gastric carcinoma model accelerated tumor growth through induction of tumor angiogenesis by decreased expression of the anti - angiogenic factor thrombospondin ( TSP) - 1.	"TGF - beta	40	50	Gene_or_gene_product"	"TGF - beta type II receptor	84	111	Gene_or_gene_product"	"gastric carcinoma	132	149	Cancer"	"tumor	168	173	Cancer"	"tumor	202	207	Cancer"	"[{""token"": ""TGF - beta"", ""start_span"": 40, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - beta type II receptor"", ""start_span"": 84, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric carcinoma"", ""start_span"": 132, ""end_span"": 149, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 168, ""end_span"": 173, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 202, ""end_span"": 207, ""type"": ""Cancer""}]"
Similar to tumors expressing dominant - negative TGF - beta type II receptor, histochemical studies revealed less fibrosis and increased angiogenesis in xenografted tumors expressing c - Ski compared to control tumors.	"tumors	11	17	Cancer"	"TGF - beta type II receptor	49	76	Gene_or_gene_product"	"tumors	165	171	Cancer"	"c - Ski	183	190	Gene_or_gene_product"	"tumors	211	217	Cancer"	"[{""token"": ""tumors"", ""start_span"": 11, ""end_span"": 17, ""type"": ""Cancer""}, {""token"": ""TGF - beta type II receptor"", ""start_span"": 49, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 165, ""end_span"": 171, ""type"": ""Cancer""}, {""token"": ""c - Ski"", ""start_span"": 183, ""end_span"": 190, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 211, ""end_span"": 217, ""type"": ""Cancer""}]"
beta2 - glycoprotein I ( beta2GPI) is proteolytically cleaved by plasmin in its domain V ( nicked beta2GPI), resulting in binding to plasminogen.	"beta2 - glycoprotein I	0	22	Gene_or_gene_product"	"beta2GPI	25	33	Gene_or_gene_product"	"plasmin	65	72	Gene_or_gene_product"	"nicked beta2GPI	91	106	Gene_or_gene_product"	"plasminogen	133	144	Gene_or_gene_product"	"[{""token"": ""beta2 - glycoprotein I"", ""start_span"": 0, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta2GPI"", ""start_span"": 25, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""plasmin"", ""start_span"": 65, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""nicked beta2GPI"", ""start_span"": 91, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""plasminogen"", ""start_span"": 133, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}]"
Dopamine pretreatment increases the translocation and colocalization of Src - homology - 2 - domain - containing protein tyrosine phosphatase ( SHP - 2) with D2DR at the cell surface.	"Dopamine	0	8	Chemical"	"Src - homology - 2 - domain - containing protein tyrosine phosphatase	72	141	Gene_or_gene_product"	"SHP - 2	144	151	Gene_or_gene_product"	"D2DR	158	162	Gene_or_gene_product"	"cell surface	170	182	Cellular_component"	"[{""token"": ""Dopamine"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical""}, {""token"": ""Src - homology - 2 - domain - containing protein tyrosine phosphatase"", ""start_span"": 72, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""SHP - 2"", ""start_span"": 144, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""D2DR"", ""start_span"": 158, ""end_span"": 162, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell surface"", ""start_span"": 170, ""end_span"": 182, ""type"": ""Cellular_component""}]"
We also observe that SHP - 2 knockdown impairs the dopamine - regulated inhibition of VEGF - induced phosphorylation of VEGFR - 2 and, subsequently, Src phosphorylation and migration.	"SHP - 2	21	28	Gene_or_gene_product"	"dopamine	51	59	Chemical"	"VEGF	86	90	Gene_or_gene_product"	"VEGFR - 2	120	129	Gene_or_gene_product"	"Src	149	152	Gene_or_gene_product"	"[{""token"": ""SHP - 2"", ""start_span"": 21, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""dopamine"", ""start_span"": 51, ""end_span"": 59, ""type"": ""Chemical""}, {""token"": ""VEGF"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 2"", ""start_span"": 120, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""Src"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}]"
To investigate how CSC contribute to tumor vascular development, we used an approach comparing tumor xenografts of the C6 glioma cell line containing either a low or a high fraction of CSC.	"CSC	19	22	Cell"	"tumor vascular	37	51	Multi"	"tumor xenografts	95	111	Cancer"	"C6 glioma cell line	119	138	Cell"	"CSC	185	188	Cell"	"[{""token"": ""CSC"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Cell""}, {""token"": ""tumor vascular"", ""start_span"": 37, ""end_span"": 51, ""type"": ""Multi""}, {""token"": ""tumor xenografts"", ""start_span"": 95, ""end_span"": 111, ""type"": ""Cancer""}, {""token"": ""C6 glioma cell line"", ""start_span"": 119, ""end_span"": 138, ""type"": ""Cell""}, {""token"": ""CSC"", ""start_span"": 185, ""end_span"": 188, ""type"": ""Cell""}]"
BACKGROUND: CDC4 / FBXW7, encoding a ubiquitin ligase, maps to 4q32 and has been implicated as a tumor suppressor gene and therapeutic target in many tumor types.	"CDC4	12	16	Gene_or_gene_product"	"FBXW7	19	24	Gene_or_gene_product"	"ubiquitin	37	46	Gene_or_gene_product"	"tumor	97	102	Cancer"	"tumor	150	155	Cancer"	"[{""token"": ""CDC4"", ""start_span"": 12, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""FBXW7"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""ubiquitin"", ""start_span"": 37, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 150, ""end_span"": 155, ""type"": ""Cancer""}]"
BI - 1 ( Bax inhibitor - 1), an apoptosis - inhibiting gene belonging to the Bcl - 2 protein family, plays an important role in mitochondrial apoptosis pathway to suppress Bax - induced apoptosis.	"BI - 1	0	6	Gene_or_gene_product"	"Bax inhibitor - 1	9	26	Gene_or_gene_product"	"Bcl - 2	77	84	Gene_or_gene_product"	"mitochondrial	128	141	Cellular_component"	"Bax	172	175	Gene_or_gene_product"	"[{""token"": ""BI - 1"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax inhibitor - 1"", ""start_span"": 9, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 77, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondrial"", ""start_span"": 128, ""end_span"": 141, ""type"": ""Cellular_component""}, {""token"": ""Bax"", ""start_span"": 172, ""end_span"": 175, ""type"": ""Gene_or_gene_product""}]"
To investigate the potential role of BI - 1 in promoting cell growth and tumorigenesis, in the present study we overexpressed the BI - 1 gene in NIH3T3 cells using the lentivirus - mediated gene expression system.	"BI - 1	37	43	Gene_or_gene_product"	"cell	57	61	Cell"	"BI - 1	130	136	Gene_or_gene_product"	"NIH3T3 cells	145	157	Cell"	"lentivirus	168	178	Organism"	"[{""token"": ""BI - 1"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Cell""}, {""token"": ""BI - 1"", ""start_span"": 130, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}, {""token"": ""NIH3T3 cells"", ""start_span"": 145, ""end_span"": 157, ""type"": ""Cell""}, {""token"": ""lentivirus"", ""start_span"": 168, ""end_span"": 178, ""type"": ""Organism""}]"
1, 4 - phenylenebis ( methylene) selenocyanate, but not selenomethionine, inhibits androgen receptor and Akt signaling in human prostate cancer cells.	"selenomethionine	56	72	Chemical"	"androgen receptor	83	100	Gene_or_gene_product"	"Akt	105	108	Gene_or_gene_product"	"human	122	127	Organism"	"prostate cancer cells	128	149	Cell"	"[{""token"": ""selenomethionine"", ""start_span"": 56, ""end_span"": 72, ""type"": ""Chemical""}, {""token"": ""androgen receptor"", ""start_span"": 83, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Organism""}, {""token"": ""prostate cancer cells"", ""start_span"": 128, ""end_span"": 149, ""type"": ""Cell""}]"
A number of signaling cascades have been shown to play important roles in prostate cancer development and progression, including the androgen receptor ( AR) and phosphatidylinositol 3 - kinase / Akt signaling pathways.	"prostate cancer	74	89	Cancer"	"androgen receptor	133	150	Gene_or_gene_product"	"AR	153	155	Gene_or_gene_product"	"phosphatidylinositol 3 - kinase	161	192	Gene_or_gene_product"	"Akt	195	198	Gene_or_gene_product"	"[{""token"": ""prostate cancer"", ""start_span"": 74, ""end_span"": 89, ""type"": ""Cancer""}, {""token"": ""androgen receptor"", ""start_span"": 133, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}, {""token"": ""AR"", ""start_span"": 153, ""end_span"": 155, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphatidylinositol 3 - kinase"", ""start_span"": 161, ""end_span"": 192, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 195, ""end_span"": 198, ""type"": ""Gene_or_gene_product""}]"
Incubation with 1 micromol / L sanguinarine for 4 and 24h killed more efficiently MG - 63 cells than SaOS - 2 cells, while incubation with 5 micromol / L sanguinarine killed almost 100% of both cell populations within 24h.	"sanguinarine	31	43	Chemical"	"MG - 63 cells	82	95	Cell"	"SaOS - 2 cells	101	115	Cell"	"sanguinarine	154	166	Chemical"	"cell populations	194	210	Cell"	"[{""token"": ""sanguinarine"", ""start_span"": 31, ""end_span"": 43, ""type"": ""Chemical""}, {""token"": ""MG - 63 cells"", ""start_span"": 82, ""end_span"": 95, ""type"": ""Cell""}, {""token"": ""SaOS - 2 cells"", ""start_span"": 101, ""end_span"": 115, ""type"": ""Cell""}, {""token"": ""sanguinarine"", ""start_span"": 154, ""end_span"": 166, ""type"": ""Chemical""}, {""token"": ""cell populations"", ""start_span"": 194, ""end_span"": 210, ""type"": ""Cell""}]"
This treatment also changed the mitochondrial membrane potential in both MG - 63 and SaOS - 2 cells within 1h, caused chromatin condensation and the formation of apoptotic bodies.	"mitochondrial membrane	32	54	Cellular_component"	"MG - 63	73	80	Cell"	"SaOS - 2 cells	85	99	Cell"	"chromatin	118	127	Cellular_component"	"apoptotic bodies	162	178	Cellular_component"	"[{""token"": ""mitochondrial membrane"", ""start_span"": 32, ""end_span"": 54, ""type"": ""Cellular_component""}, {""token"": ""MG - 63"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""SaOS - 2 cells"", ""start_span"": 85, ""end_span"": 99, ""type"": ""Cell""}, {""token"": ""chromatin"", ""start_span"": 118, ""end_span"": 127, ""type"": ""Cellular_component""}, {""token"": ""apoptotic bodies"", ""start_span"": 162, ""end_span"": 178, ""type"": ""Cellular_component""}]"
When TB4 expression in B16F10 cells was inhibited by the infection with small hairpin ( sh) RNA of TB4 cloned in lentiviral vector, tumor cell migration was retarded.	"TB4	5	8	Gene_or_gene_product"	"B16F10 cells	23	35	Cell"	"TB4	99	102	Gene_or_gene_product"	"lentiviral	113	123	Organism"	"tumor cell	132	142	Cell"	"[{""token"": ""TB4"", ""start_span"": 5, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""B16F10 cells"", ""start_span"": 23, ""end_span"": 35, ""type"": ""Cell""}, {""token"": ""TB4"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""lentiviral"", ""start_span"": 113, ""end_span"": 123, ""type"": ""Organism""}, {""token"": ""tumor cell"", ""start_span"": 132, ""end_span"": 142, ""type"": ""Cell""}]"
HIF - 1alpha stabilization and the expression of VEGF isoform 165 and 121 in hypoxia were also reduced by the infection of lentiviral shRNA of TB4 in B16F10 cells.	"HIF - 1alpha	0	12	Gene_or_gene_product"	"VEGF	49	53	Gene_or_gene_product"	"lentiviral	123	133	Organism"	"TB4	143	146	Gene_or_gene_product"	"B16F10 cells	150	162	Cell"	"[{""token"": ""HIF - 1alpha"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""lentiviral"", ""start_span"": 123, ""end_span"": 133, ""type"": ""Organism""}, {""token"": ""TB4"", ""start_span"": 143, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""B16F10 cells"", ""start_span"": 150, ""end_span"": 162, ""type"": ""Cell""}]"
In vivo studies, CT26 cancer cells were implanted into BALB / c mice and groups of mice were treated with vehicle, DATS ( 10 and 50 mg / kg of body weight).	"CT26 cancer cells	17	34	Cell"	"BALB / c mice	55	68	Organism"	"mice	83	87	Organism"	"DATS	115	119	Chemical"	"body	143	147	Organism_subdivision"	"[{""token"": ""CT26 cancer cells"", ""start_span"": 17, ""end_span"": 34, ""type"": ""Cell""}, {""token"": ""BALB / c mice"", ""start_span"": 55, ""end_span"": 68, ""type"": ""Organism""}, {""token"": ""mice"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Organism""}, {""token"": ""DATS"", ""start_span"": 115, ""end_span"": 119, ""type"": ""Chemical""}, {""token"": ""body"", ""start_span"": 143, ""end_span"": 147, ""type"": ""Organism_subdivision""}]"
The expression of HMGA2 modulates the expression of hTERT, resulting in cells with enhanced telomerase activities and increased telomere length.	"HMGA2	18	23	Gene_or_gene_product"	"hTERT	52	57	Gene_or_gene_product"	"cells	72	77	Cell"	"telomerase	92	102	Gene_or_gene_product"	"telomere	128	136	Cellular_component"	"[{""token"": ""HMGA2"", ""start_span"": 18, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""hTERT"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 72, ""end_span"": 77, ""type"": ""Cell""}, {""token"": ""telomerase"", ""start_span"": 92, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""telomere"", ""start_span"": 128, ""end_span"": 136, ""type"": ""Cellular_component""}]"
Moreover, HMGA2 knockdown by short hairpin HMGA2 in HepG2 cells leads to progressive telomere shortening and a concurrent decrease of steady - state hTERT mRNA levels, attenuating their ability to form colonies in soft agar.	"HMGA2	10	15	Gene_or_gene_product"	"HMGA2	43	48	Gene_or_gene_product"	"HepG2 cells	52	63	Cell"	"telomere	85	93	Cellular_component"	"hTERT	149	154	Gene_or_gene_product"	"[{""token"": ""HMGA2"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""HMGA2"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""HepG2 cells"", ""start_span"": 52, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""telomere"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Cellular_component""}, {""token"": ""hTERT"", ""start_span"": 149, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}]"
Aglycon of rhizochalin from the Rhizochalina incrustata induces apoptosis via activation of AMP - activated protein kinase in HT - 29 colon cancer cells.	"Aglycon	0	7	Chemical"	"rhizochalin	11	22	Chemical"	"Rhizochalina incrustata	32	55	Organism"	"AMP - activated protein kinase	92	122	Gene_or_gene_product"	"HT - 29 colon cancer cells	126	152	Cell"	"[{""token"": ""Aglycon"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""rhizochalin"", ""start_span"": 11, ""end_span"": 22, ""type"": ""Chemical""}, {""token"": ""Rhizochalina incrustata"", ""start_span"": 32, ""end_span"": 55, ""type"": ""Organism""}, {""token"": ""AMP - activated protein kinase"", ""start_span"": 92, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""HT - 29 colon cancer cells"", ""start_span"": 126, ""end_span"": 152, ""type"": ""Cell""}]"
Overall, our findings identify AMPK as an important target protein for mediating the anti - tumor properties of AglRhz in HT - 29 colon cancer cells and have important implication for sponges, the most important marine source, in colon cancer.	"AMPK	31	35	Gene_or_gene_product"	"tumor	92	97	Cancer"	"AglRhz	112	118	Chemical"	"HT - 29 colon cancer cells	122	148	Cell"	"colon cancer	230	242	Cancer"	"[{""token"": ""AMPK"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Cancer""}, {""token"": ""AglRhz"", ""start_span"": 112, ""end_span"": 118, ""type"": ""Chemical""}, {""token"": ""HT - 29 colon cancer cells"", ""start_span"": 122, ""end_span"": 148, ""type"": ""Cell""}, {""token"": ""colon cancer"", ""start_span"": 230, ""end_span"": 242, ""type"": ""Cancer""}]"
Expression of thymidylate synthase and dihydropyrimidine dehydrogenase in primary oral squamous cell carcinoma and corresponding metastases in cervical lymph nodes: association with the metastasis suppressor CD82.	"thymidylate synthase	14	34	Gene_or_gene_product"	"dihydropyrimidine dehydrogenase	39	70	Gene_or_gene_product"	"primary oral squamous cell carcinoma	74	110	Cancer"	"cervical lymph nodes	143	163	Multi"	"CD82	208	212	Gene_or_gene_product"	"[{""token"": ""thymidylate synthase"", ""start_span"": 14, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""dihydropyrimidine dehydrogenase"", ""start_span"": 39, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""primary oral squamous cell carcinoma"", ""start_span"": 74, ""end_span"": 110, ""type"": ""Cancer""}, {""token"": ""cervical lymph nodes"", ""start_span"": 143, ""end_span"": 163, ""type"": ""Multi""}, {""token"": ""CD82"", ""start_span"": 208, ""end_span"": 212, ""type"": ""Gene_or_gene_product""}]"
Although 5 - FU is often used for the treatment of oral carcinoma, there has not been any investigation into the expression of these enzymes in metastatic lymph nodes or of their roles in the effectiveness of 5 - FU in treating lymph node - metastatic cancer.	"5 - FU	9	15	Chemical"	"oral carcinoma	51	65	Cancer"	"metastatic lymph nodes	144	166	Multi"	"5 - FU	209	215	Chemical"	"lymph node - metastatic cancer	228	258	Cancer"	"[{""token"": ""5 - FU"", ""start_span"": 9, ""end_span"": 15, ""type"": ""Chemical""}, {""token"": ""oral carcinoma"", ""start_span"": 51, ""end_span"": 65, ""type"": ""Cancer""}, {""token"": ""metastatic lymph nodes"", ""start_span"": 144, ""end_span"": 166, ""type"": ""Multi""}, {""token"": ""5 - FU"", ""start_span"": 209, ""end_span"": 215, ""type"": ""Chemical""}, {""token"": ""lymph node - metastatic cancer"", ""start_span"": 228, ""end_span"": 258, ""type"": ""Cancer""}]"
These findings indicate that TS and CD82 may be of great value in assessing lymph node metastasis of OSCC, and could be taken as new targets for therapy of metastatic OSCC.	"TS	29	31	Gene_or_gene_product"	"CD82	36	40	Gene_or_gene_product"	"lymph node	76	86	Multi"	"OSCC	101	105	Cancer"	"OSCC	167	171	Cancer"	"[{""token"": ""TS"", ""start_span"": 29, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD82"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 76, ""end_span"": 86, ""type"": ""Multi""}, {""token"": ""OSCC"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Cancer""}, {""token"": ""OSCC"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Cancer""}]"
Impaired CK1 delta activity attenuates SV40 - induced cellular transformation in vitro and mouse mammary carcinogenesis in vivo.	"CK1 delta	9	18	Gene_or_gene_product"	"SV40	39	43	Organism"	"cellular	54	62	Cell"	"mouse	91	96	Organism"	"mammary	97	104	Organ"	"[{""token"": ""CK1 delta"", ""start_span"": 9, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV40"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Organism""}, {""token"": ""cellular"", ""start_span"": 54, ""end_span"": 62, ""type"": ""Cell""}, {""token"": ""mouse"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Organism""}, {""token"": ""mammary"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Organ""}]"
Various cellular kinases, among them members of the CK1 family, play an important role in modulating the transforming activity of SV40, including the transforming activity of T - Ag, the major transforming protein of SV40, itself.	"cellular	8	16	Cell"	"CK1	52	55	Gene_or_gene_product"	"SV40	130	134	Organism"	"T - Ag	175	181	Gene_or_gene_product"	"SV40	217	221	Organism"	"[{""token"": ""cellular"", ""start_span"": 8, ""end_span"": 16, ""type"": ""Cell""}, {""token"": ""CK1"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV40"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Organism""}, {""token"": ""T - Ag"", ""start_span"": 175, ""end_span"": 181, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV40"", ""start_span"": 217, ""end_span"": 221, ""type"": ""Organism""}]"
The reduced CK1delta activity did not affect early lesion formation during tumorigenesis, suggesting that impaired CK1delta activity reduces the probability for outgrowth of in situ carcinomas to invasive carcinomas.	"CK1delta	12	20	Gene_or_gene_product"	"lesion	51	57	Pathological_formation"	"CK1delta	115	123	Gene_or_gene_product"	"in situ carcinomas	174	192	Cancer"	"invasive carcinomas	196	215	Cancer"	"[{""token"": ""CK1delta"", ""start_span"": 12, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""lesion"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Pathological_formation""}, {""token"": ""CK1delta"", ""start_span"": 115, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}, {""token"": ""in situ carcinomas"", ""start_span"": 174, ""end_span"": 192, ""type"": ""Cancer""}, {""token"": ""invasive carcinomas"", ""start_span"": 196, ""end_span"": 215, ""type"": ""Cancer""}]"
Our data show that inactivating mutations in CK1delta impair SV40 - induced cellular transformation in vitro and mouse mammary carcinogenesis in vivo.	"CK1delta	45	53	Gene_or_gene_product"	"SV40	61	65	Organism"	"cellular	76	84	Cell"	"mouse	113	118	Organism"	"mammary	119	126	Organ"	"[{""token"": ""CK1delta"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV40"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Organism""}, {""token"": ""cellular"", ""start_span"": 76, ""end_span"": 84, ""type"": ""Cell""}, {""token"": ""mouse"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Organism""}, {""token"": ""mammary"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Organ""}]"
Cells were perifused in the presence of 5 mM glucose, 0. 5 mM glutamine or 5 mM glucose and 0. 5 mM glutamine.	"Cells	0	5	Cell"	"glucose	45	52	Chemical"	"glutamine	62	71	Amino_acid"	"glucose	80	87	Chemical"	"glutamine	100	109	Amino_acid"	"[{""token"": ""Cells"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Cell""}, {""token"": ""glucose"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Chemical""}, {""token"": ""glutamine"", ""start_span"": 62, ""end_span"": 71, ""type"": ""Amino_acid""}, {""token"": ""glucose"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Chemical""}, {""token"": ""glutamine"", ""start_span"": 100, ""end_span"": 109, ""type"": ""Amino_acid""}]"
However, by treatment with Ha - ras oncogenes derived from a human lung carcinoma or Harvey murine sarcoma virus, the KMST - 6 cells acquired elevated clonability in soft agar and transplantability in nude mice.	"Ha - ras	27	35	Gene_or_gene_product"	"human lung carcinoma	61	81	Organism"	"Harvey murine sarcoma virus	85	112	Organism"	"KMST - 6 cells	118	132	Cell"	"nude mice	201	210	Organism"	"[{""token"": ""Ha - ras"", ""start_span"": 27, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""human lung carcinoma"", ""start_span"": 61, ""end_span"": 81, ""type"": ""Organism""}, {""token"": ""Harvey murine sarcoma virus"", ""start_span"": 85, ""end_span"": 112, ""type"": ""Organism""}, {""token"": ""KMST - 6 cells"", ""start_span"": 118, ""end_span"": 132, ""type"": ""Cell""}, {""token"": ""nude mice"", ""start_span"": 201, ""end_span"": 210, ""type"": ""Organism""}]"
The Ha - ras oncogene alone did not convert normal human fibroblasts into either immortal or tumorigenic cells.	"Ha - ras	4	12	Gene_or_gene_product"	"human	51	56	Organism"	"fibroblasts	57	68	Cell"	"immortal	81	89	Cell"	"tumorigenic cells	93	110	Cell"	"[{""token"": ""Ha - ras"", ""start_span"": 4, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Organism""}, {""token"": ""fibroblasts"", ""start_span"": 57, ""end_span"": 68, ""type"": ""Cell""}, {""token"": ""immortal"", ""start_span"": 81, ""end_span"": 89, ""type"": ""Cell""}, {""token"": ""tumorigenic cells"", ""start_span"": 93, ""end_span"": 110, ""type"": ""Cell""}]"
New Zealand white rabbits were given limbal inoculations of a heat - killed suspension of herpes simplex virus ( HSV) in a lysate of human embryonic kidney cells.	"New Zealand white rabbits	0	25	Organism"	"herpes simplex virus	90	110	Organism"	"HSV	113	116	Organism"	"human	133	138	Organism"	"embryonic kidney cells	139	161	Cell"	"[{""token"": ""New Zealand white rabbits"", ""start_span"": 0, ""end_span"": 25, ""type"": ""Organism""}, {""token"": ""herpes simplex virus"", ""start_span"": 90, ""end_span"": 110, ""type"": ""Organism""}, {""token"": ""HSV"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Organism""}, {""token"": ""embryonic kidney cells"", ""start_span"": 139, ""end_span"": 161, ""type"": ""Cell""}]"
Finally, anti - p53 monoclonal antibodies only slightly affected in vitro phosphorylation reactions, whereas a p53 molecule from a simian virus 40 - free, chemically transformed human cell line was not phosphorylated in vitro under any condition tested.	"anti - p53 monoclonal antibodies	9	41	Gene_or_gene_product"	"p53	111	114	Gene_or_gene_product"	"simian virus 40	131	146	Organism"	"human	178	183	Organism"	"cell line	184	193	Cell"	"[{""token"": ""anti - p53 monoclonal antibodies"", ""start_span"": 9, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""simian virus 40"", ""start_span"": 131, ""end_span"": 146, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 178, ""end_span"": 183, ""type"": ""Organism""}, {""token"": ""cell line"", ""start_span"": 184, ""end_span"": 193, ""type"": ""Cell""}]"
Southern blotting and probing with PCR - synthesized cDNA fragments of the mouse 72 kDa type IV collagenase gene showed that this gene was present in all cells although the structure of this gene in one of the three LTA cell lines differed from that of the other cells.	"mouse	75	80	Organism"	"72 kDa type IV collagenase	81	107	Gene_or_gene_product"	"cells	154	159	Cell"	"LTA cell lines	216	230	Cell"	"cells	263	268	Cell"	"[{""token"": ""mouse"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Organism""}, {""token"": ""72 kDa type IV collagenase"", ""start_span"": 81, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 154, ""end_span"": 159, ""type"": ""Cell""}, {""token"": ""LTA cell lines"", ""start_span"": 216, ""end_span"": 230, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 263, ""end_span"": 268, ""type"": ""Cell""}]"
Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin - 3 and BM - 40 / SPARC genes.	"human	26	31	Organism"	"colorectal cancer	32	49	Cancer"	"stromelysin - 3	91	106	Gene_or_gene_product"	"BM - 40	111	118	Gene_or_gene_product"	"SPARC	121	126	Gene_or_gene_product"	"[{""token"": ""human"", ""start_span"": 26, ""end_span"": 31, ""type"": ""Organism""}, {""token"": ""colorectal cancer"", ""start_span"": 32, ""end_span"": 49, ""type"": ""Cancer""}, {""token"": ""stromelysin - 3"", ""start_span"": 91, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""BM - 40"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""SPARC"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}]"
Comparative NMR study of a differentiated rat hepatoma and its dedifferentiated subclone cultured as spheroids and as implanted tumors.	"rat	5	8	Organism"	"hepatoma	46	54	Cancer"	"subclone	80	88	Cell"	"spheroids	101	110	Cell"	"tumors	128	134	Cancer"	"[{""token"": ""rat"", ""start_span"": 5, ""end_span"": 8, ""type"": ""Organism""}, {""token"": ""hepatoma"", ""start_span"": 46, ""end_span"": 54, ""type"": ""Cancer""}, {""token"": ""subclone"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Cell""}, {""token"": ""spheroids"", ""start_span"": 101, ""end_span"": 110, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Cancer""}]"
31P MR spectra showed that phosphocreatine was present in H5 spheroids but not in H4 spheroids or tumors.	"31P	0	3	Chemical"	"phosphocreatine	27	42	Chemical"	"H5 spheroids	58	70	Cell"	"H4 spheroids	82	94	Cell"	"tumors	98	104	Cancer"	"[{""token"": ""31P"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Chemical""}, {""token"": ""phosphocreatine"", ""start_span"": 27, ""end_span"": 42, ""type"": ""Chemical""}, {""token"": ""H5 spheroids"", ""start_span"": 58, ""end_span"": 70, ""type"": ""Cell""}, {""token"": ""H4 spheroids"", ""start_span"": 82, ""end_span"": 94, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 98, ""end_span"": 104, ""type"": ""Cancer""}]"
Thus the results obtained by 31P and 13C MRS correlated with the differentiation state of H4 and H5 spheroids and tumors.	"31P	29	32	Chemical"	"13C	37	40	Chemical"	"H4	90	92	Cell"	"H5 spheroids	97	109	Cell"	"tumors	114	120	Cancer"	"[{""token"": ""31P"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Chemical""}, {""token"": ""13C"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Chemical""}, {""token"": ""H4"", ""start_span"": 90, ""end_span"": 92, ""type"": ""Cell""}, {""token"": ""H5 spheroids"", ""start_span"": 97, ""end_span"": 109, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 114, ""end_span"": 120, ""type"": ""Cancer""}]"
Comparison between RNA / DNA sequence of viral oncogenes and normal human genome of non - transformed cells revealed high sequence similarities in specific genomic areas, which were named cellular proto - oncogens.	"DNA	25	28	Cellular_component"	"viral	41	46	Organism"	"human	68	73	Organism"	"cells	102	107	Cell"	"cellular	188	196	Cell"	"[{""token"": ""DNA"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Cellular_component""}, {""token"": ""viral"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 68, ""end_span"": 73, ""type"": ""Organism""}, {""token"": ""cells"", ""start_span"": 102, ""end_span"": 107, ""type"": ""Cell""}, {""token"": ""cellular"", ""start_span"": 188, ""end_span"": 196, ""type"": ""Cell""}]"
Monoclonal antibody targeted therapy directed against EGF - R or Her - 2 / neu, the use of anti - sense oligonucleotides and oligodeoxynucleotides, and the application of tyrosine kinase and protein C - kinase inhibitors are currently being investigated.	"EGF - R	54	61	Gene_or_gene_product"	"Her - 2	65	72	Gene_or_gene_product"	"neu	75	78	Gene_or_gene_product"	"tyrosine kinase	171	186	Gene_or_gene_product"	"protein C - kinase	191	209	Gene_or_gene_product"	"[{""token"": ""EGF - R"", ""start_span"": 54, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""Her - 2"", ""start_span"": 65, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""neu"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""tyrosine kinase"", ""start_span"": 171, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}, {""token"": ""protein C - kinase"", ""start_span"": 191, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}]"
Sequencing of exons 5 through 8 of the p53 gene revealed no mutations, nor were mutations detected in the N - or K - ras protooncogenes in four of the carcinomas and their respective metastatic deposits.	"p53	39	42	Gene_or_gene_product"	"N -	106	109	Gene_or_gene_product"	"K - ras	113	120	Gene_or_gene_product"	"carcinomas	151	161	Cancer"	"deposits	194	202	Cancer"	"[{""token"": ""p53"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""N -"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""K - ras"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""carcinomas"", ""start_span"": 151, ""end_span"": 161, ""type"": ""Cancer""}, {""token"": ""deposits"", ""start_span"": 194, ""end_span"": 202, ""type"": ""Cancer""}]"
These results suggest that point mutations in p53 and ras are not associated with pituitary tumorigenesis, however, point mutations of the H - ras gene may be important in the formation and or growth of pituitary metastases.	"p53	46	49	Gene_or_gene_product"	"ras	54	57	Gene_or_gene_product"	"pituitary	82	91	Organ"	"H - ras	139	146	Gene_or_gene_product"	"pituitary metastases	203	223	Cancer"	"[{""token"": ""p53"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""ras"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""pituitary"", ""start_span"": 82, ""end_span"": 91, ""type"": ""Organ""}, {""token"": ""H - ras"", ""start_span"": 139, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""pituitary metastases"", ""start_span"": 203, ""end_span"": 223, ""type"": ""Cancer""}]"
None of the tumors or the healthy breast in the tissues studied expressed Glut - 3 or Glut - 5.	"tumors	12	18	Cancer"	"healthy breast	26	40	Tissue"	"tissues	48	55	Tissue"	"Glut - 3	74	82	Gene_or_gene_product"	"Glut - 5	86	94	Gene_or_gene_product"	"[{""token"": ""tumors"", ""start_span"": 12, ""end_span"": 18, ""type"": ""Cancer""}, {""token"": ""healthy breast"", ""start_span"": 26, ""end_span"": 40, ""type"": ""Tissue""}, {""token"": ""tissues"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Tissue""}, {""token"": ""Glut - 3"", ""start_span"": 74, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""Glut - 5"", ""start_span"": 86, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}]"
High density of somatostatin receptors in veins surrounding human cancer tissue: role in tumor - host interaction?	"somatostatin receptors	16	38	Gene_or_gene_product"	"veins	42	47	Multi"	"human	60	65	Organism"	"cancer tissue	66	79	Tissue"	"tumor	89	94	Cancer"	"[{""token"": ""somatostatin receptors"", ""start_span"": 16, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""veins"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Multi""}, {""token"": ""human"", ""start_span"": 60, ""end_span"": 65, ""type"": ""Organism""}, {""token"": ""cancer tissue"", ""start_span"": 66, ""end_span"": 79, ""type"": ""Tissue""}, {""token"": ""tumor"", ""start_span"": 89, ""end_span"": 94, ""type"": ""Cancer""}]"
In contrast, the incidence and density of somatostatin receptors in peritumoral vessels was low in well - differentiated gastrointestinal and bronchial carcinoids, in contrast to the high density of such receptors in the carcinoid tumor tissue.	"somatostatin receptors	42	64	Gene_or_gene_product"	"peritumoral vessels	68	87	Multi"	"gastrointestinal	121	137	Cancer"	"bronchial carcinoids	142	162	Cancer"	"carcinoid tumor tissue	221	243	Tissue"	"[{""token"": ""somatostatin receptors"", ""start_span"": 42, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""peritumoral vessels"", ""start_span"": 68, ""end_span"": 87, ""type"": ""Multi""}, {""token"": ""gastrointestinal"", ""start_span"": 121, ""end_span"": 137, ""type"": ""Cancer""}, {""token"": ""bronchial carcinoids"", ""start_span"": 142, ""end_span"": 162, ""type"": ""Cancer""}, {""token"": ""carcinoid tumor tissue"", ""start_span"": 221, ""end_span"": 243, ""type"": ""Tissue""}]"
Autochthonous vessels surrounding other tumors such as renal - cell carcinomas or malignant lymphomas also frequently expressed somatostatin receptors.	"vessels	14	21	Multi"	"tumors	40	46	Cancer"	"renal - cell carcinomas	55	78	Cancer"	"malignant lymphomas	82	101	Cancer"	"somatostatin receptors	128	150	Gene_or_gene_product"	"[{""token"": ""vessels"", ""start_span"": 14, ""end_span"": 21, ""type"": ""Multi""}, {""token"": ""tumors"", ""start_span"": 40, ""end_span"": 46, ""type"": ""Cancer""}, {""token"": ""renal - cell carcinomas"", ""start_span"": 55, ""end_span"": 78, ""type"": ""Cancer""}, {""token"": ""malignant lymphomas"", ""start_span"": 82, ""end_span"": 101, ""type"": ""Cancer""}, {""token"": ""somatostatin receptors"", ""start_span"": 128, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}]"
Metastasis - associated 5T4 antigen disrupts cell - cell contacts and induces cellular motility in epithelial cells.	"5T4	24	27	Gene_or_gene_product"	"cell	45	49	Cell"	"cell	52	56	Cell"	"cellular	78	86	Cell"	"epithelial cells	99	115	Cell"	"[{""token"": ""5T4"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Cell""}, {""token"": ""cellular"", ""start_span"": 78, ""end_span"": 86, ""type"": ""Cell""}, {""token"": ""epithelial cells"", ""start_span"": 99, ""end_span"": 115, ""type"": ""Cell""}]"
Transfection of full - length 5T4 cDNA into epithelial cells alters cell - cell contacts and cellular motility.	"5T4	30	33	Gene_or_gene_product"	"epithelial cells	44	60	Cell"	"cell	68	72	Cell"	"cell	75	79	Cell"	"cellular	93	101	Cell"	"[{""token"": ""5T4"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""epithelial cells"", ""start_span"": 44, ""end_span"": 60, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Cell""}, {""token"": ""cellular"", ""start_span"": 93, ""end_span"": 101, ""type"": ""Cell""}]"
The in vitro expression of FAK and its level of phosphorylation appear to be related to several physiological phenomena, including cell spreading, cell differentiation, cell locomotion and cell death.	"FAK	27	30	Gene_or_gene_product"	"cell	131	135	Cell"	"cell	147	151	Cell"	"cell	169	173	Cell"	"cell	189	193	Cell"	"[{""token"": ""FAK"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 189, ""end_span"": 193, ""type"": ""Cell""}]"
